The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Magenta Therapeutics, Inc(NASDAQ:MGTA)


Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops novel medicines to bring the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy to patients. The company is developing C100 and C300 targeted antibody-drug conjugates for transplant condi...
Website: http://www.magentatx.com
Founded: 2015
Full Time Employees: 70
Sector: Healthcare
Industry: Biotechnology
Magenta Therapeutics Op Cashflow Per Share ttm
Magenta Therapeutics Free Cashflow Per Share ttm
Magenta Therapeutics Cash Per Share ttm
Magenta Therapeutics P/S ratio ttm
Magenta Therapeutics (GAAP) P/E ratio ttm
Magenta Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.